INS and type 1 diabetes mellitus: In addition to adverse effects on insulin sensitivity, elevated plasma BCAAs stimulate insulin secretion, deplete insulin reserves in early type 1 diabetes, impair pancreatic β cell function, and ultimately leads to insulin deficiency (30).